Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
Part of paid clinical trials in Watkinsville, Georgia.
- Sponsor
- University Surgical Vascular
- Study ID
- NCT06647017
- Status
- Recruiting
Conditions
- Blood Loss, Surgical
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Volta tAN System — DEVICETranscutaneous auricular neurostimulation (tAN)
- SHAM Volta tAN System — DEVICEParticipants randomized to the sham group will have an earpiece applied, but stimulation will not be turned on.
Study Details
The objective of this study is to determine if tAN therapy can reduce the volume of blood lost during dialysis AV graft placement procedures.
Key Dates
- Start date
- Nov 13, 2024
- Status verified
- May 2026
- Primary completion
- Nov 15, 2026
- Completion
- Nov 15, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active tAN + standard of careParticipants randomized to the active group will have an earpiece applied and receive 30 minutes of active tAN therapy immediately prior to the dialysis port placement procedure. When the 30-minute tAN session is complete, the system will be turned off, unplugged, and the earpiece will be removed.
- Sham Comparator: Sham tAN + standard of careParticipants randomized to the sham group will have an earpiece applied, but stimulation will not be turned on. These participants will receive 30 minutes of sham tAN therapy immediately prior to the dialysis port placement procedure. When the 30-minute tAN session is complete, the system will be turned off, unplugged, and the earpiece will be removed.
Primary Outcome Measure
Mean Total Blood Loss [ Time Frame: Throughout procedure ]
Central Contacts
- David Sailors, MD(706) 549-8306
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Surgical Vascular | Watkinsville | Georgia | 30677 | David Sailors, MD David Sailors, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Watkinsville, GA
By research site
Related Studies
- Quantra QPlus in Pediatric Cardiovascular ProceduresNot Yet Recruiting · HemoSonics LLC · Los Angeles, California
- Tranexamic Acid in Adult Spinal Deformity SurgeryPHASE3 · Recruiting · Hospital for Special Surgery, New York · New York, New York
- Role of TXA in Patients Undergoing Breast Free Flap ReconstructionPHASE4 · Recruiting · University of Virginia · Charlottesville, Virginia
- Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine AtonyPHASE2 · Recruiting · University of Michigan · Ann Arbor, Michigan